Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Journal of Dairy Science
|
December 16, 2003
Phosphorus feeding levels and critical control points on dairy farms
Z Dou, J D Ferguson, J Fiorini, et al.
The American Journal of Cardiology
|
March 19, 2002
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
Moti L Kashyap, Mark E McGovern, Kathleen Berra, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
Development of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational Screening
Joshua W Powell, Chelsea A Mann, Paul D Toth, et al.
Scientific Reports
|
August 10, 2022
Proof of concept for developing novel feeds for cattle from wasted food and crop biomass to enhance agri-food system efficiency
Zhengxia Dou, John D Toth, Dipti W Pitta, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 17, 2008
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus
K C Maki, L L Curry, M S Reeves, et al.
Clinical Therapeutics
|
September 18, 2001
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies
H E Bays, P B Moore, M A Drehobl, et al.
Journal of Human Hypertension
|
April 1, 1997
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension
R Fiddes, J Blumenthal, J E Dawson, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 17, 2008
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure
K C Maki, L L Curry, M C Carakostas, et al.
The New England Journal of Medicine
|
April 1, 2014
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia
Dirk J Blom, Tomas Hala, Michael Bolognese, et al.
The British Journal of Dermatology
|
February 26, 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K A Papp, K Reich, C Paul, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Journal of Dairy Science
|
December 16, 2003
Phosphorus feeding levels and critical control points on dairy farms
Z Dou, J D Ferguson, J Fiorini, et al.
The American Journal of Cardiology
|
March 19, 2002
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
Moti L Kashyap, Mark E McGovern, Kathleen Berra, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
Development of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational Screening
Joshua W Powell, Chelsea A Mann, Paul D Toth, et al.
Scientific Reports
|
August 10, 2022
Proof of concept for developing novel feeds for cattle from wasted food and crop biomass to enhance agri-food system efficiency
Zhengxia Dou, John D Toth, Dipti W Pitta, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 17, 2008
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus
K C Maki, L L Curry, M S Reeves, et al.
Clinical Therapeutics
|
September 18, 2001
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies
H E Bays, P B Moore, M A Drehobl, et al.
Journal of Human Hypertension
|
April 1, 1997
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension
R Fiddes, J Blumenthal, J E Dawson, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 17, 2008
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure
K C Maki, L L Curry, M C Carakostas, et al.
The New England Journal of Medicine
|
April 1, 2014
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia
Dirk J Blom, Tomas Hala, Michael Bolognese, et al.
The British Journal of Dermatology
|
February 26, 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K A Papp, K Reich, C Paul, et al.
Page
of 10